The critical importance of the regulation of IL-6 trans-signaling through the blood-brain-barrier has been demonstrated in central nervous system inflammation, as well as in neurodegenerative and neuropsychiatric disorders, such as Alzheimer’s and Parkinson’s [reviewed in (22, 23)]. The gene discussed is IL6; the disease is Parkinsonism.